Liver Cancer Cell Lines
Database

LCCL to predict drug response

Drug: Tivantinib

DrugsAliasTargetsTargeted cellular functionClinical status in any tumor typeClinical status in HCCSupplierReference
Tivantinib ARQ197 Microtubule * Mitosis * Phase 1, 2, 3 Phase 3 Selleck Chemicals S2753

Cell Line (34)
Cell LineAUCGI50
HCC.1.10.510.105
SNU8780.560.086
HepaRG0.590.305
HLE0.610.21
JHH40.630.353
SNU8860.640.5
JHH70.650.345
JHH50.660.42
Huh70.690.55
SNU7390.70.595
Huh60.70.545
JHH60.70.755
HCC.1.20.710.615
SNU4230.711.11
SNU3980.721.08


LCCL transcriptomic subgroup:
CL1
CL2
CL3
undef.

Codebase Soc. Coop.
info@codebase.it